HomeXRTX • NASDAQ
add
XORTX Therapeutics Inc
Previous close
$0.44
Day range
$0.42 - $0.47
Year range
$0.37 - $1.41
Market cap
4.18M CAD
Avg Volume
250.42K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 579.09K | 27.41% |
Net income | -590.46K | -581.87% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -571.99K | -28.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 864.51K | -65.05% |
Total assets | 2.68M | -34.46% |
Total liabilities | 599.07K | -20.97% |
Total equity | 2.08M | — |
Shares outstanding | 6.96M | — |
Price to book | 1.45 | — |
Return on assets | -52.70% | — |
Return on capital | -69.69% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -590.46K | -581.87% |
Cash from operations | -701.86K | 20.82% |
Cash from investing | -264.26K | -6,447.50% |
Cash from financing | 632.53K | -42.86% |
Net change in cash | -329.40K | -290.51% |
Free cash flow | -802.77K | 37.38% |
About
Founded
2011
Headquarters
Website
Employees
3
